Abstract
Extra-fine particle formulations of hydrofluoroalkane-134a beclometasone dipropionate (HFA-BDP) exhibit clinical effects comparable with conventional particle formulations of chlorofluorocarbon beclometasone dipropionate (CFC-BDP) at half the dose. There is little data comparing their effects on inflammation. We have evaluated the effects of HFA-BDP and CFC-BDP on pulmonary and systemic markers of asthmatic inflammation.
Original language | English |
---|---|
Pages (from-to) | 661-667 |
Number of pages | 7 |
Journal | Allergy |
Volume | 62 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2007 |
Keywords
- Acetates
- Administration, Inhalation
- Adrenal Cortex Hormones
- Anti-Asthmatic Agents
- Anti-Inflammatory Agents
- Asthma
- Beclomethasone
- Chemistry, Pharmaceutical
- Chlorofluorocarbons
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Eosinophils
- Humans
- Hydrocarbons, Fluorinated
- Inflammation
- Nitric Oxide
- Particle Size
- Quinolines